K-V Pharmaceutical reports $1.57 million of operating income for April

By Caroline Salls

Pittsburgh, May 15 - K-V Pharmaceutical Co. posted operating income of $1.57 million for April on net revenues of $8.33 million, according to its monthly operating report filed Wednesday with the U.S. Bankruptcy Court for the Southern District of New York.

Those figures compare to operating income of $1.76 million for March on net revenues of $7.06 million.

The net loss from continuing operations was $3.52 million in April, widening from a $1.14 million March net loss from continuing operations.

The company also reported $35.75 million in cash and cash equivalents as of April 30, down from $37.25 million at the end of March.

K-V Pharmaceutical, a St. Louis specialty pharmaceutical company, filed for bankruptcy on Aug. 4, 2012. The Chapter 11 case number is 12-13346.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.